DOI QR코드

DOI QR Code

Recurrence of Subepithelial Non-Muscle Invasive Bladder Cancer Following Transurethral Resection: A Case Report

비근침윤성 방광암의 경요도절제술 후 방광 내 상피하종양 형태의 재발: 증례 보고

  • Nokjung Kim (Department of Radiology, Kyung Hee University Hospital) ;
  • Sung Kyoung Moon (Department of Radiology, Kyung Hee University Hospital) ;
  • Myung-won You (Department of Radiology, Kyung Hee University Hospital) ;
  • Joo Won Lim (Department of Radiology, Kyung Hee University Hospital)
  • 김녹정 (경희대학교병원 영상의학과) ;
  • 문성경 (경희대학교병원 영상의학과) ;
  • 유명원 (경희대학교병원 영상의학과) ;
  • 임주원 (경희대학교병원 영상의학과)
  • Received : 2020.05.29
  • Accepted : 2020.08.09
  • Published : 2021.05.01

Abstract

Transurethral resection (TUR) is the gold standard treatment of non-muscle invasive bladder cancers. Recurrence occurs in approximately half of the patients with bladder cancer after initial TUR. Most recurrent bladder cancers present as polypoid masses with intraluminal growth originating from the mucosa. To the best of our knowledge, there has been no report on imaging findings of recurrent bladder cancers located within the subepithelial and intramural layers. Recurrent cancers within the intramural layer are difficult to detect with cystoscopy; they are also difficult to remove surgically. Imaging studies reveal the most important indicators for diagnosing subepithelial recurrent cancers. Here, we present a rare case of a recurrent bladder cancer within the subepithelial layer detected on imaging.

방광암의 경요도절제술은 비근침윤성 방광암의 1차 치료 방법이다. 첫 번째 경요도절제술 이후 약 절반가량의 방광암 환자에서 재발을 보인다. 대부분의 방광암 재발은 방광점막에서 방광내막 쪽으로 자라는 용종 모양의 종괴로 나타난다. 지금까지 알려진 바에 의하면, 재발한 방광암이 상피하종양의 형태로 보고된 증례는 없다. 근육내층에 국한된 재발암은 방광경에서 발견하기가 쉽지 않고, 또한 수술적으로 완전히 제거하는 것 역시 쉽지 않다. 근육내층에 재발한 방광암을 진단하는 데에 있어서 영상 검사가 가장 중요한 정보를 제공할 수 있다. 이 증례에서는 영상 검사에서 진단할 수 있는 아주 드문 상피하 재발 방광암에 대해 보고하고자 한다.

Keywords

References

  1. Cumberbatch MGK, Foerster B, Catto JWF, Kamat AM, Kassouf W, Jubber I, et al. Repeat transurethral resection in non-muscle-invasive bladder cancer: a systematic review. Eur Urol 2018;73:925-933 https://doi.org/10.1016/j.eururo.2018.02.014
  2. Bansal A, Sankhwar S, Goel A, Kumar M, Purkait B, Aeron R. Grading of complications of transurethral resection of bladder tumor using Clavien-Dindo classification system. Indian J Urol 2016;32:232-237 https://doi.org/10.4103/0970-1591.185104
  3. Wong-You-Cheong JJ, Woodward PJ, Manning MA, Sesterhenn IA. From the archives of the AFIP: neoplasms of the urinary bladder: radiologic-pathologic correlation. Radiographics 2006;26:553-580 https://doi.org/10.1148/rg.262055172
  4. Yoshida S, Koga F, Kobayashi S, Tanaka H, Satoh S, Fujii Y, et al. Diffusion-weighted magnetic resonance imaging in management of bladder cancer, particularly with multimodal bladder-sparing strategy. World J Radiol 2014;6:344-354 https://doi.org/10.4329/wjr.v6.i6.344
  5. Antoine G. van der Heijden JAW. Recurrence, progression, and follow-up in non-muscle-invasive bladder cancer. Eur Urol Suppl 2009;8:556-562 https://doi.org/10.1016/j.eursup.2009.06.010
  6. Kim JH, Yang WJ. Delayed spontaneous perforation of urinary bladder with intraperitoneal seeding following radical transurethral resection of invasive urothelial cancer: a case report. BMC Res Notes 2014;7:167
  7. Golan S, Baniel J, Lask D, Livne PM, Yossepowitch O. Transurethral resection of bladder tumour complicated by perforation requiring open surgical repair-clinical characteristics and oncological outcomes. BJU Int 2011;107:1065-1068 https://doi.org/10.1111/j.1464-410X.2010.09696.x
  8. Mydlo JH, Weinstein R, Shah S, Solliday M, Macchia RJ. Long-term consequences from bladder perforation and/or violation in the presence of transitional cell carcinoma: results of a small series and a review of the literature. J Urol 1999;161:1128-1132 https://doi.org/10.1016/S0022-5347(01)61608-2
  9. Bus MT, Cordeiro ER, Anastasiadis A, Klioueva NM, De la Rosette JJ, De Reijke TM. Urothelial carcinoma in both adnexa following perforation during transurethral resection of a non-muscle-invasive bladder tumor: a case report and literature review. Expert Rev Anticancer Ther 2012;12:1529-1536 https://doi.org/10.1586/era.12.136
  10. Engilbertsson H, Aaltonen KE, Bjornsson S, Kristmundsson T, Patschan O, Ryden L, et al. Transurethral bladder tumor resection can cause seeding of cancer cells into the bloodstream. J Urol 2015;193:53-57 https://doi.org/10.1016/j.juro.2014.06.083